A key on-chain metric tracking the balance between Bitcoin held at a profit versus a loss is nearing a convergence point that has historically aligned with major bear market lows, offering a potential beacon for long-term investors.
Aristotle Capital's latest investor letter reveals Uber (UBER) was a significant portfolio detractor in Q4 2025, as a broad market shift toward value stocks and away from high-growth names pressured the ride-hailing giant's shares despite a resilient economic backdrop.
Industrial manufacturer IDEX Corporation (NYSE:IEX) reported stronger-than-expected fourth-quarter revenue of $899.1 million, surpassing analyst estimates. However, a deeper look reveals slowing organic growth and margin pressures that temper the headline beat.
NWPX Infrastructure, Inc. (NASDAQ:NWPX) finds itself firmly in the hands of institutional investors, whose collective 83% ownership grants them significant influence over the company's direction. This concentration comes as the energy sector watches potential policy shifts under a new administration.
As GE HealthCare Technologies (GEHC) prepares to report quarterly earnings, investors are weighing anticipated revenue growth against recent stock weakness. The spotlight is also on the newly cleared Allia Moveo imaging system, seen as a key growth driver in a competitive medtech landscape.
WeRide's stock has plummeted 48% over the past year, leaving investors to grapple with a stark contradiction: a DCF model suggests massive undervaluation, while its sky-high P/S ratio screams overvaluation. We examine the numbers, the narrative, and what it means for the autonomous driving pioneer's future.
HP Inc. faces a period of unexpected leadership change as CEO Enrique Lores departs for PayPal. With interim CEO Bruce Broussard at the helm and a search underway, the company reaffirms its 2026 earnings outlook, signaling stability amidst uncertainty for the PC and printing giant.
Avery Dennison (NYSE: AVY) reported fourth-quarter revenue of $2.27 billion, a 3.9% year-over-year increase that fell short of Wall Street expectations. However, adjusted earnings per share of $2.45 surpassed consensus estimates by 2.9%, highlighting a quarter of resilient profitability amid challenging market conditions.
As Bitcoin's price struggles to find a floor, analysts point to a critical and seemingly calm indicator—the US corporate credit spread—as the potential trigger for the next major move. The current divergence between compressed credit risk and falling crypto prices suggests markets may be underpricing looming stress.
Boston Scientific (NYSE:BSX) reported fourth-quarter revenue of $5.29 billion, aligning with Wall Street forecasts and marking a 15.9% year-over-year increase. The medical device giant also posted adjusted earnings of $0.80 per share, slightly above consensus, while providing guidance in line with expectations for the coming quarter.
Senior executives at Dutch wealth manager Van Lanschot Kempen have made significant personal investments in the company's stock over the past year, a move widely interpreted as a strong vote of confidence in its future trajectory.
Amid a strong start for major indices, a look at three lesser-known companies where recent insider buying activity hints at underlying value and management confidence.
As Iran and the U.S. prepare to resume nuclear negotiations, Tehran's expansive and hardened ballistic missile program remains a non-negotiable pillar of its defense strategy. This analysis examines the capabilities, strategy, and regional impact of one of the Middle East's largest missile arsenals.
As major indices rally on strong economic data, savvy investors are turning their attention to lesser-known companies with solid fundamentals. We analyze three small-cap stocks that combine financial resilience with attractive valuations in the current climate.
Michael Burry, the investor famed for predicting the 2008 financial crisis, warns that Bitcoin's sharp decline could trigger cascading liquidations and expose vulnerabilities in corporate treasuries and tokenized markets.
Weyerhaeuser (WY) shares have surged over 18% in the past three months, reigniting discussions about whether the timber and real estate investment trust remains undervalued or if the market is getting ahead of itself.
Recent volatility in Ipsos (ENXTPA:IPS) shares has investors questioning whether the stock's current price of €34.76 represents a buying opportunity, given a significant gap to some fair value estimates. We examine the data behind the valuation debate and the risks involved.
Analysts have raised their price target for school bus manufacturer Blue Bird (BLBD) to $76, signaling renewed optimism following better-than-expected quarterly results and a robust near-term forecast, even as the firm's core fair value estimate holds steady.
Thule Group's shares have faced significant pressure, declining 12% over the past three months. As the stock trades around SEK 214, a stark divergence emerges between its market price and analyst fair value estimates of SEK 282, igniting discussions on whether this represents a buying opportunity or reflects deeper sectoral headwinds.
LiveRamp Holdings' shares have tumbled nearly 70% over five years, presenting a stark contrast between its discounted cash flow valuation and its premium trading multiples. As the market grapples with its positioning, investors are left weighing deep-seated pessimism against potential hidden value.
